Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Gastroenterology
    • Prolonged use of...

    Prolonged use of heartburn medicines increases risk of pneumonia in Elderly

    Written by Vinay Singh singh Published On 2018-08-25T19:25:27+05:30  |  Updated On 25 Aug 2018 7:25 PM IST
    Prolonged use of heartburn medicines increases risk of pneumonia in Elderly
    Researchers have found that long-term use of heartburn medicines increases the risk of pneumonia in Elderly.

    The use of proton pump inhibitors (PPIs) is associated with greater risk of pneumonia in the second year of treatment in older adults in primary care, reports a study published in the Journal of the American Geriatrics Society. The study revealed that PPIs treated participants had greater comorbidity (54.2%) than controls (36.2%).


    Jan Zirk Sadowski and his associates did a longitudinal analysis of electronic medical records to estimate associations between long‐term use of proton pump inhibitors (PPIs) and pneumonia incidence in older adults in primary care. The analysis involved 75050 individuals aged 60 and older in primary care receiving PPIs for 1 year or longer.


    The investigators found that during the second year after initiating treatment, PPIs were associated with greater hazard of incident pneumonia, accounting for pretreatment pneumonia rates with similar estimates across age and comorbidity subgroups.


    Read Also: PPIs and antibiotics in infancy lead to allergic diseases later : JAMA


    “We have demonstrated for the first time a clear increase in long‐term pneumonia incidence associated with ongoing PPI use after accounting for preexisting differences in pneumonia rates between treated and control groups,” write the authors.


    The study concluded that the risk of pneumonia is greater with long‐term PPI therapy in older adults in primary care, independent of excess pneumonia rates immediately before first PPI receipt. The study showed, the excess risk was statistically similar across age and comorbidity groups, but the authors warrant that more research is needed to identify individuals at highest risk.


    Proton-pump inhibitors (PPIs) are the medicines commonly prescribed to reduce gastric acid and to protect the stomach, thereby preventing stomach ulcers or heartburn. PPIs act directly on H+/K+‐ ATPase enzymes, reducing acid secretion.


    For reference log on to https://doi.org/10.1111/jgs.15385


    comorbidityelderlyinhibitorJan Zirk SadowskiJournal of the American Geriatrics Societylong termpneumoniaPPIPrimary CareProlongedprotonpumpside effectstreatment
    Source : With inputs from Journal of the American Geriatrics Society

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok